Cardio Diagnostics Announces Publication of Study Showing That Its PrecisionCHD Test Could Save Health Insurers Over $113 Million Annually

The Peer-Reviewed Publication Demonstrates the Potential Economic Benefits of the PrecisionCHD Test for the Detection and Management of Coronary Heart Disease, which is One of the Largest Cost Centers for Public

BusinesswireApr 29 20:31

Sector Update: Health Care Stocks Advance Late Afternoon

Health care stocks were higher late Friday afternoon, with the NYSE Health Care Index rising 0.3% and the Health Care Select Sector SPDR Fund (XLV) adding 0.4%. The iShares Biotechnology ETF (IBB) dec

MT NewswiresApr 20 04:00

Top Midday Decliners

Luna Innovations (LUNA) said its audit committee, after consultation with its management and external legal and financial advisers, concluded financial statements for some accounting periods "cannot b

MT NewswiresApr 20 01:52

Cardio Diagnostics Is Maintained at Speculative Buy by Benchmark

Cardio Diagnostics Is Maintained at Speculative Buy by Benchmark

Dow JonesApr 19 19:57

Benchmark: Maintaining the Cardio Diagnostics Hldgs (CDIO.US) rating, adjusted from Speculative Buy to Specified Buy, and adjusted the target price from $4.00 to $1.35.

Benchmark: Maintaining the Cardio Diagnostics Hldgs (CDIO.US) rating, adjusted from Speculative Buy to Specified Buy, and adjusted the target price from $4.00 to $1.35.

Zhitong FinanceApr 19 19:50

Benchmark Maintains Speculative Buy on Cardio Diagnostics Hldgs, Lowers Price Target to $1.35

Benchmark analyst Bruce Jackson maintains Cardio Diagnostics Hldgs with a Speculative Buy and lowers the price target from $4 to $1.35.

Analyst UpgradesApr 19 19:47